| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/05/2002 | EP1210424A1 Novel b7-4 molecules and uses therefor |
| 06/05/2002 | EP1210422A2 Human abc2 transporter and uses thereof |
| 06/05/2002 | EP1210419A2 Human transmembrane proteins |
| 06/05/2002 | EP1210374A1 Human monoclonal antibodies to prostate specific membrane antigen |
| 06/05/2002 | EP1210372A2 Human monoclonal antibodies to her2/neu |
| 06/05/2002 | EP1210370A1 Human tumor necrosis factor receptor tr16 |
| 06/05/2002 | EP1210357A1 OLIGONUCLEOTIDE N3'$m(7)P5' THIOPHOSPHORAMIDATES: THEIR SYNTHESIS AND USE |
| 06/05/2002 | EP1210355A2 Glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 06/05/2002 | EP1210354A1 Prodrugs for liver specific drug delivery |
| 06/05/2002 | EP1210350A1 Water soluble sdz-rad esters |
| 06/05/2002 | EP1210348A1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 06/05/2002 | EP1210346A2 New active marine alkaloids |
| 06/05/2002 | EP1210341A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 06/05/2002 | EP1210335A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
| 06/05/2002 | EP1210327A2 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 06/05/2002 | EP1210326A2 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 06/05/2002 | EP1210127A1 Radiopharmaceutical products and their preparation procedure |
| 06/05/2002 | EP1210121A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 06/05/2002 | EP1210119A1 Pharmaceutical compositions for oral and topical administration |
| 06/05/2002 | EP1210115A1 DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 06/05/2002 | EP1210113A2 Combined vaccine compositions |
| 06/05/2002 | EP1210110A1 Prion protein binding proteins and uses thereof |
| 06/05/2002 | EP1210109A2 Utilization of an aminopeptidase inhibitor |
| 06/05/2002 | EP1210108A2 Use of leptin in inhibition of endothelial cell proliferation |
| 06/05/2002 | EP1210099A1 Methods and compositions useful for modulation of angiogenesis using protein kinase raf and ras |
| 06/05/2002 | EP1210097A1 A pharmaceutical ayurvedic preparation |
| 06/05/2002 | EP1210093A1 Degradable polymers |
| 06/05/2002 | EP1210079A2 A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress |
| 06/05/2002 | EP1210078A1 Improved topical medicaments and methods for photodynamic treatment of disease |
| 06/05/2002 | EP1210065A1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 06/05/2002 | EP1210063A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 06/05/2002 | EP1209986A1 Metal-containing compositions, preparations and uses |
| 06/05/2002 | EP1137438B1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 06/05/2002 | EP1121117B1 Oxaliplatinum preparation packaging |
| 06/05/2002 | EP1117420B1 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues |
| 06/05/2002 | EP1109817B1 Phosphohalohydrins, method for making same and uses |
| 06/05/2002 | EP1105379B1 Water soluble analogs and prodrugs of paclitaxel |
| 06/05/2002 | EP1037658B1 Ifnar/ifn complex |
| 06/05/2002 | EP0975592B1 Benzyloxy prodigiosine compounds |
| 06/05/2002 | EP0944628B1 Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents |
| 06/05/2002 | EP0851855B1 Acylated derivatives of melatonin and its analogues, useful as medicaments |
| 06/05/2002 | EP0799046B1 Stable solutions of 2-chloro-2'-deoxyadenosine |
| 06/05/2002 | EP0788361B1 Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids |
| 06/05/2002 | EP0752870B1 Use of mycobacterium for the treatment of tumours |
| 06/05/2002 | EP0736095B1 Human circulating cytokine cc-1 |
| 06/05/2002 | EP0711282B1 Compounds as pde iv and tnf inhibitors |
| 06/05/2002 | CN1352687A A variant of c6 beta-chemokine leukotactin-1 (shLKn-1) with enhanced biological activity |
| 06/05/2002 | CN1352683A Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/05/2002 | CN1352646A Camptothecin analogs and methods of preparation thereof |
| 06/05/2002 | CN1352644A I-amino triazolo [4,3-alpha] quinazoline -5-ones and/or -5-thiones inhibiting phosphodiesterase IV |
| 06/05/2002 | CN1352642A Farnesyl protein transferase inhibitors |
| 06/05/2002 | CN1352635A Quinoline derivatives as inhibitors of MEK enzymes |
| 06/05/2002 | CN1352568A Water soluble compositions for bioactive lipophilic compounds |
| 06/05/2002 | CN1352563A Use of phyllanthus for targeted stimulation of the immune system |
| 06/05/2002 | CN1352561A Method for enhancing the efficacy of anti-tumor agents |
| 06/05/2002 | CN1352545A 吲哚衍生物 Indole derivatives |
| 06/05/2002 | CN1352391A Novel anti-tumor medicine and its screening method and use |
| 06/05/2002 | CN1352087A New polypeptide-human glycoprotein 42 and polynucleotide for encoding such polypeptide |
| 06/05/2002 | CN1352041A New polypeptide-ciliary taktin 45.98 and polynucleotide for encoding such polypeptide |
| 06/05/2002 | CN1351985A Process for producing veratryl alcohol and its use in food, drink and grape wind |
| 06/05/2002 | CN1351885A Anti-cancer Chinese medicine formula |
| 06/05/2002 | CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists |
| 06/04/2002 | US6399797 Vitamin D analogues |
| 06/04/2002 | US6399780 Kinase inhibitors; anticancer agents |
| 06/04/2002 | US6399773 Autoimmune disease; transplanting organs |
| 06/04/2002 | US6399657 Antiinflammatory agents |
| 06/04/2002 | US6399653 Ring fused dihydropyrans, process for preparation and use thereof |
| 06/04/2002 | US6399647 Amide derivatives for antiangiogenic and/or antitumorigenic use |
| 06/04/2002 | US6399643 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations formed therefrom |
| 06/04/2002 | US6399642 Tris benzimidazoles; fungicides, anticarcinogenic agents, enzyme inhibitor |
| 06/04/2002 | US6399638 Anticarcinogenic agents; microtubule stabilizing effects |
| 06/04/2002 | US6399637 Crystal modification of torasemide |
| 06/04/2002 | US6399636 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease (copd), eosinophilic granuloma, psoriasis and septic shock, ulcerative colitis, crohn's disease, reperfusion injury of the myocardium and brain |
| 06/04/2002 | US6399634 Benzothiophene compounds, compositions, and methods |
| 06/04/2002 | US6399633 Flavopiridol; low dosage; vascular lesions after ballon or stent |
| 06/04/2002 | US6399626 Useful in inducing immunosuppression and in treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, vascular disease |
| 06/04/2002 | US6399620 Cycloalkyl derivatives as inhibitors of bone resporption and vitronectin receptor antagonists |
| 06/04/2002 | US6399615 Farnesyl protein transferase inhibitors |
| 06/04/2002 | US6399603 Therapeutic heterocycles |
| 06/04/2002 | US6399602 Anticancer agents |
| 06/04/2002 | US6399595 Steroid sulfatase inhibitors and methods for making and using the same |
| 06/04/2002 | US6399593 Contraceptives |
| 06/04/2002 | US6399589 Viricides; antitumor agents |
| 06/04/2002 | US6399588 Cancer treatment method utilizing plasmids suitable for IL-2 expression |
| 06/04/2002 | US6399583 Hybrid anthracyclines from genetically engineered streptomyces galilaeus strains, process for production and uses thereof |
| 06/04/2002 | US6399372 Monocyte derived cells with immunostimulating properties, their preparation and uses |
| 06/04/2002 | US6399328 Amino acid sequence; hybridization probes; amplification primers; anticarcinogenic agents; antitumor agents |
| 06/04/2002 | US6399312 Myostatin gene promoter and inhibition of activation thereof |
| 06/04/2002 | US6399297 Antisense modulation of expression of tumor necrosis factor receptor-associated factors (TRAFs) |
| 06/04/2002 | US6399139 Controlling material handling |
| 06/04/2002 | US6399079 Spill resistant pharmaceutical compositions in semi-solid form |
| 06/04/2002 | US6399070 Heat shock protein complex for immunology |
| 06/04/2002 | US6399069 Purification and prevention of disease with heat shock protein bound to antigens |
| 06/04/2002 | US6399068 Cancer treatment, interleukins, fusion proteins, cell markers |
| 06/04/2002 | US6399063 Monoclonal antibodies directed to the HER2 receptor |
| 06/04/2002 | US6399061 Monoclonal secreted by atcc deposit no. hb11388 and transfectoma tcae8 accorded atcc deposit no. 69119; parenteral injection |
| 06/04/2002 | CA2257016C Imidazolidin-4-one derivatives useful as anticancer agents |
| 06/01/2002 | CA2325666A1 Immunogenic mutated peptides derived from r9m, polynucleotides, coding polynucleotides and their therapeutic uses |
| 05/30/2002 | WO2002042777A2 Modulation of the interaction between evh1 domains |
| 05/30/2002 | WO2002042776A2 Compositions and methods relating to prostate specific genes and proteins |